| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10930503 | Cytotherapy | 2015 | 12 Pages |
Abstract
The use of treated MSCs may achieve clinical end points not reached with untreated MSCs and allow for infusion of fewer cells to reduce costs and minimize potential side effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
John Girdlestone, Jeffrey Pido-Lopez, Saket Srivastava, Jianguo Chai, Neil Leaver, Antonio Galleu, Giovanna Lombardi, Cristina V. Navarrete,